Higher DKK1 and sclerostin but lower Z-scores were detected in the T1DM subjects than in the controls. Treatment with insulin via continuous subcutaneous infusion improved glycaemic control and Z-scores in the T1DM subjects compared to treatment with insulin via multiple daily injections. This evidence concerns the gene DKK1 and type 1 diabetes mellitus.